Skip to main content
. Author manuscript; available in PMC: 2019 Sep 3.
Published in final edited form as: Mod Pathol. 2018 Sep 4;32(1):27–36. doi: 10.1038/s41379-018-0120-9

Figure 3:

Figure 3:

Morphologic spectrum of MYOD1-mutant rhabdomyosarcoma following therapy. (A-C) Case 4 showing sclerosing areas on the pre-therapy biopsy (A), while in the post-therapy resection (B,C) showing pure spindle cell morphology; (D-F) Case 12 showing a sclerosing morphology in the pre-therapy biopsy (D), while the post-therapy resection reveals a spindle cell morphology (E) and areas of maturation with rhabdomyoblastic morphology (F); (G-I) Case 24 showing spindle cell morphology on pre-therapy biopsy (G), while post-therapy resection shows cellular spindle cell areas (H) and areas of maturation (I). (H&E stains)